Phase 4 Type 2 Diabetes Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults aged 18 or older who have been diagnosed with both type 2 diabetes and chronic kidney disease
- A blood sugar control measurement (HbA1c) between 7.0% and 11%
- A urine test result (albumin-to-creatinine ratio) between 300 and 5000 mg/g, which indicates a certain level of kidney protein leakage
- A body mass index (a height-to-weight ratio) between 21 and 45 kg/m²
- People who have been taking a combination of two specific medications — an SGLT2 inhibitor and finerenone — for at least 3 months, alongside the highest tolerated dose of a blood pressure/kidney-protective medication called a RAS inhibitor
- People who are willing to give formal written consent, understand how the trial works, and agree to follow the trial rules closely
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- Women who are pregnant, breastfeeding, or of childbearing age who are not willing to use reliable contraception
- People who have a known medical reason they cannot take GLP-1 receptor agonist medications, SGLT2 inhibitors, or finerenone, or who have not been able to tolerate these medications in the past
- People who have type 1 diabetes
- People who have had a serious diabetes complication called diabetic ketoacidosis within the past 6 months
- People whose kidneys are functioning below a certain threshold, specifically an eGFR (a measure of kidney filtering ability) below 30 mL/min/1.73 m²
- People who were hospitalised in the 30 days before screening for a serious heart event such as a heart attack, emergency heart procedure, or heart surgery
- People with poorly controlled high blood pressure, measured as 160 mmHg or higher (top number) and/or 100 mmHg or higher (bottom number) at the time of screening
- People with very low blood pressure (below 90 mmHg top number) or symptoms of low blood pressure, or those the trial doctor considers to be low in fluid volume
- People with a potassium level above 5.0 mmol/L in their blood at the time of screening
- People who are currently taking, or have taken within the past 3 months, a GLP-1 receptor agonist medication or certain other medications that affect a hormone pathway in the kidneys (mineralocorticoid receptor antagonists, such as spironolactone)
- People who are receiving, or clearly need, medications that suppress the immune system (such as prednisone or cyclosporine) for other kidney conditions such as lupus nephritis or glomerulonephritis
- People with a history of recurring urinary tract or genital infections, as assessed by the trial doctor
- People whose life expectancy at the time of screening is less than one year
- People who have a confirmed cancer diagnosis
- People who have participated in another clinical trial within the 3 months before screening
- People whom the trial doctor considers unsuitable for participation for any other reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0553-5739315
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Urine Albumin-to-Creatinine Ratio（UACR）
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.